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L. COICADAN~ M. mYMANf E. G R A S S E T *~~~ J.F. DESJEUX. INSERM U 83 and DBpartement d e PBdiatrie (Univ. Paris VII), Hdpital HBrold, 75935, Paris, France. Cystinuria : absence of lysine permeability in the brush border membrane of intestinal cells.
The mechanism of impaired transport of cystine and dibasic amino acids in the jejunum and the kidney of cystinuric patients is poorly understood. Na-dependent Llysine intestinal transport has been assessed, in vitro, by measurement of intracellular accumulation and of unidirectional influx across the brush border membrane in per ora biopsies performed for diagnostic purpose on 27 "control' children and 2 cystinuric patients, in the presence of 3 mM lysine in the incubation solution. The project was accepted by the Committee on Ethics of the Department of Pediatrics of the University Paris VII. In cystinuria 1) the Na-dependent lysine intracellular accumulation is abolished, 2) the Na-independent accumulation persists (the accumulation ratio is 1.69 * 0.341, 3) the lysine influx in pmol/h cm2 a t the luminal*membrane is hardly measurable both i n the presence (0.17 * 0.03) and in the absence of Na (0.22 ' 0.09). Control values : 0.95 * 0.14 in the presence of Na and 0.57 * 0.08 in the absence of Na. These.results suggest a specific loss of the Na-dependent L-lysine transport at the luminal membrane of the enterocytes of the intestine in the 2 patients with cystinuria. The lysine permeability at the baso-lateral membrane is probably present. We have shown previously, that the activity of cerebrosulfotransferase (CST) a microsomal enzyme involved i n myelin synthesis 1 s modulated in vitro by the cholesterol-phospholipid ratio (C/P) in microsomal membranes. To further investi ate this mechanism, we studied two different models: 1. rose from 32002340 dpm to 6'300+5tiC dgm. After this aeriod C/P and CST activity r e t k e d to normal. ! . e therefore speculate that microsomal CST activity is modulated by changes i n membrane fluidity, which is caused by changes i n the molar-ratio of cholesterol to phospholipid i n microsomes.
Elevation of erythrocyte galactose-1-Phosphate (Gal-1-P) in children with double heterozygosity 39 for Duarte variant and galartosemia. Schwarz H.P., Zuppinger K., Zimmermann A., Dauwalder H. and Scherz R., Department of Pediatrics, University of Berne, Switzer-land.
In 1977 a partial deficiency of Gal-1-P uridyl transferase (Gal-1-PUT) .was found in 0.015% of 73691 Beutler tests performed by Swiss laboratories for neonatal screening. Some of these cases with marked reduction of Gal-1-PUT activity (mean 18% of normal) were identified as double heterozygotes for Duarte variant and galactosemia (2-0). Fasting plasma galactose concentrations did not exceed 2.2 mg/dl in 19 (2-0) patients and 1.4 mg/dl in agematched controls, erythrocyte (Ec) Gal-1-P varied between 0-1.6 mg/dl in both groups. Oral galactose tolerance tests (lg/kg b.w.) were done in all (2-0) patients: 6 neonates (A), 6 infants after 1 year of galactose-free diet (B) and 7 patients (age 1.8-18.6 years) who had never received a diet (C). Peak plasma galactose levels were reached at 60 or 90 min. in all subjects. Gal-1-P reached 6.0-22.7 mg/dl Ec in A, 3.7-31.3 mg/dl in E and 6.0-11.7 mg/dl in C at 60 min. By contrast, in controls, maximum Gal-1-P levels never exceeded 2.7 mg/dl. As Gal-1-P is the incriminated toxic agent in galactosemia, this finding may be of pathophysiological importance. citrulline and lysine.
LPI is an autosomal recessive defect of diamino acid transport in renal tubular and intestinal epithelium, and hepatocytes. This leads to deficiency of ornithine and other urea cycle intermediates, and inadequate function of the cycle which results in hyperamonemia after protein intake, and protein aversion. Lysine shortage may contribute to the growth failure of the patients.
Our patients have earlier been treated with an arginine supplement. We have now shown that, while the intestinal absorption is very poor for arginine, it is intact for citrulline, another urea cycle intermediate. Since autumn 1976 our patients have been given 1.5 g/kg of dietary protein daily supplemented with 2-3 g citrulline and 1-2 g lysine. The protein aversion decreased in 13/21 patients, growth accelerated in 12/21, and urinary orbtic acid excretion rate normalized in 9/11 as a sign of improved nitrogen tolerance. 4 patients had very fragile and sparse hair; this normalized during the therapy. Gastrointestinal complaints appeared during the treatment in 6/21; these disappeared when lysine supplementation was stopped. Hepato-and splenomegalia, increased plasma lactate dehydrogenase, leukocytopenia and trombocytopenia, and fasting plasma and urinary amino acids remained unchanged. They may depend on lysine deficiency. The severe intestinal transport defect of lysine seems to invalidate the oral route for lysine supplementation.
We suggest that citrulline, possibly with lysine, should replace arginine in the treatment of LPI. . , Hereditary tyrosinemia -furnarylacetoacetase deficiency.
